Suppr超能文献

促动力药物的处方模式和药物不良反应。

Prescription pattern & adverse drug reactions of prokinetics.

机构信息

Department of Clinical Pharmacology, Seth Gordhandas Sunderdas Medical College & King Edward Memorial Hospital, Mumbai, India.

Department of Pharmacology & Therapeutics, Seth Gordhandas Sunderdas Medical College & King Edward Memorial Hospital, Mumbai, India.

出版信息

Indian J Med Res. 2019 Jun;149(6):748-754. doi: 10.4103/ijmr.IJMR_1039_17.

Abstract

BACKGROUND & OBJECTIVES: Prokinetics are extensively prescribed leading to several adverse events (AEs). The aim of this study was to assess the prescription pattern in patients receiving prokinetics, and characteristics of adverse drug reactions (ADRs) in an outpatient department set up in a tertiary care hospital in western India.

METHODS

Patients attending outpatient departments of a tertiary care hospital and who had received prokinetic agent for at least seven days over the last one month were enrolled. Causality assessment of AEs was done and assessed for severity, preventability, seriousness and predictability.

RESULTS

A total of 304 patients [161 males (52.96%); 143 females (47.04%)] were enrolled. Most prescriptions (299/304, 98%) included domperidone, most commonly prescribed as fixed-dose combination (FDC) with pantoprazole (274/304, 90%). Prokinetic dose was not mentioned in 251/304 (83%) prescriptions, and 18/304 (6%) did not mention frequency. Of the 378 AEs reported from 179 patients (47.35%), 306 (81%) were mild, all non-serious; 272 (72%) not preventable and 291 (77%) predictable in nature. Decreased appetite (n=31, 8.2%) and fatigue (n=27,7.14%) were most commonly reported. Causality assessment by the World Health Organization-Uppsala Monitoring Centre scale showed that 180 AEs were related to suspected drug (17 probable and 163 possible ADRs). Significant correlation was observed for AEs with increasing number of drugs per prescription (Spearman's R=+0.8, P =0.05) and with increasing therapy duration (Spearman's R=+1.00, P <0.001).

INTERPRETATION & CONCLUSIONS: Our findings showed that prokinetics were often prescribed as FDCs, with incomplete prescriptions. Domperidone was found to be associated with multiple AEs. It is suggested that regular prescription monitoring should be done in hospitals to encourage rational use of drugs.

摘要

背景与目的

促动力药的应用非常广泛,导致了多种不良反应(AE)。本研究的目的是评估在印度西部一家三级保健医院的门诊部中接受促动力药治疗的患者的处方模式,并评估不良反应(ADR)的特征。

方法

纳入在过去一个月内至少接受了促动力药治疗 7 天的三级保健医院门诊部患者。对 AE 的因果关系进行评估,并评估其严重程度、可预防性、严重性和可预测性。

结果

共纳入 304 例患者[161 例男性(52.96%);143 例女性(47.04%)]。大多数处方(299/304,98%)包括多潘立酮,最常见的是与泮托拉唑的固定剂量组合(FDC)(274/304,90%)。在 251/304(83%)处方中未提及促动力药剂量,18/304(6%)未提及频率。在 179 例患者(47.35%)中报告了 378 例不良反应(AE),其中 306 例(81%)为轻度,均非严重;272 例(72%)不可预防,291 例(77%)可预测。最常见的报告不良反应为食欲不振(n=31,8.2%)和疲劳(n=27,7.14%)。世界卫生组织-乌普萨拉监测中心量表的因果关系评估显示,180 例 AE 与可疑药物相关(17 例可能和 163 例可能的 ADR)。AE 与处方中每增加一种药物的数量(Spearman's R=+0.8,P=0.05)和治疗持续时间(Spearman's R=+1.00,P<0.001)呈显著相关。

解释与结论

我们的研究结果表明,促动力药常作为 FDC 处方,且处方不完整。多潘立酮与多种不良反应相关。建议医院应定期进行处方监测,以鼓励合理用药。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ce5f/6755782/17c9be4fb2e6/IJMR-149-748-g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验